Transcriptional targeting of B cells with viral vectors

European Journal of Cell Biology

Volumn 91, Issue 1, 2012, Pages 86-96

  Friedrich, Romana I ^a   Nopora, Katrin ^a   Brocker, Thomas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

B cells; Bone marrow chimeras; Cell specific expression; Gene therapy; Lentivirus; Retrovirus

Indexed keywords

LENTIVIRUS VECTOR; RETROVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIGENS, CD19; B-LYMPHOCYTES; BONE MARROW; FLOW CYTOMETRY; GAMMA RAYS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LENTIVIRUS; MICE; MICE, INBRED C57BL; MOLECULAR TARGETED THERAPY; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; RETROVIRIDAE; TRANSDUCTION, GENETIC; TRANSGENES; WHOLE-BODY IRRADIATION;

LENTIVIRUS; MUS;

EID: 84855976264     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2011.01.016     Document Type: Article

References (47)

1. Agarwal R.K., Kang Y., Zambidis E., Scott D.W., Chan C.C., Caspi R.R. Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J. Clin. Invest. 2000, 106:245-252.
2. Allen G.C., Spiker S., Thompson W.F. Use of matrix attachment regions (MARs) to minimize transgene silencing. Plant Mol. Biol. 2000, 43:361-376.
3. Anderson W.F. Gene therapy. The best of times, the worst of times. Science 2000, 288:627-629.
4. Bank A., Dorazio R., Leboulch P. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia. Ann. N. Y. Acad. Sci. 2005, 1054:308-316.
5. Baum C., Dullmann J., Li Z., Fehse B., Meyer J., Williams D.A., Von Kalle C. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 2003, 101:2099-2113.
6. Buckley R.H. The multiple causes of human SCID. J. Clin. Invest. 2004, 114:1409-1411.
7. Buhlmann J.E., Foy T.M., Aruffo A., Crassi K.M., Ledbetter J.A., Green W.R., Xu J.C., Shultz L.D., Roopesian D., Flavell R.A., et al. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 1995, 2:645-653.
8. Chen C., Rivera A., Ron N., Dougherty J.P., Ron Y. A gene therapy approach for treating T-cell-mediated autoimmune diseases. Blood 2001, 97:886-894.
9. Chen C.C., Rivera A., Dougherty J.P., Ron Y., Chen C., Ron N. Complete protection from relapsing experimental autoimmune encephalomyelitis induced by syngeneic B cells expressing the autoantigen: a gene therapy approach for treating T-cell-mediated autoimmune diseases. Blood 2004, 103:4616-4618.
10. Desiderio S. Role of Btk in B cell development and signaling. Curr. Opin. Immunol. 1997, 9:534-540.
11. Dresch C., Edelmann S.L., Marconi P., Brocker T. Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo. J. Immunol. 2008, 181:4495-4506.
12. El-Amine M., Melo M., Kang Y., Nguyen H., Qian J., Scott D.W. Mechanisms of tolerance induction by a gene-transferred peptide-IgG fusion protein expressed in B lineage cells. J. Immunol. 2000, 165:5631-5636.
13. Forrester W.C., van Genderen C., Jenuwein T., Grosschedl R. Dependence of enhancer-mediated transcription of the immunoglobulin mu gene on nuclear matrix attachment regions. Science 1994, 265:1221-1225.
14. Fujimoto M., Poe J.C., Inaoki M., Tedder T.F. CD19 regulates B lymphocyte responses to transmembrane signals. Semin. Immunol. 1998, 10:267-277.
15. Gisler R., Akerblad P., Sigvardsson M. A human early B-cell factor-like protein participates in the regulation of the human CD19 promoter. Mol. Immunol. 1999, 36:1067-1077.
16. Hacein-Bey-Abina S., von Kalle C., Schmidt M., Le Deist F., Wulffraat N., McIntyre E., Radford I., Villeval J.L., Fraser C.C., Cavazzana-Calvo M., Fischer A. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 2003 a, 348:255-256.
17. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M.P., Wulffraat N., Leboulch P., Lim A., Osborne C.S., Pawliuk R., Morillon E., Sorensen R., Forster A., Fraser P., Cohen J.I., de Saint Basile G., Alexander I., Wintergerst U., Frebourg T., Aurias A., Stoppa-Lyonnet D., Romana S., Radford-Weiss I., Gross F., Valensi F., Delabesse E., Macintyre E., Sigaux F., Soulier J., Leiva L.E., Wissler M., Prinz C., Rabbitts T.H., Le Deist F., Fischer A., Cavazzana-Calvo M. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003, 302:415-419.
18. Hematti P., Hong B.K., Ferguson C., Adler R., Hanawa H., Sellers S., Holt I.E., Eckfeldt C.E., Sharma Y., Schmidt M., von Kalle C., Persons D.A., Billings E.M., Verfaillie C.M., Nienhuis A.W., Wolfsberg T.G., Dunbar C.E., Calmels B. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol. 2004, 2:e423.
19. Hollsberg P., Batra V., Dressel A., Hafler D.A. Induction of anergy in CD8 T cells by B cell presentation of antigen. J. Immunol. 1996, 157:5269-5276.
20. Jenuwein T., Forrester W.C., Fernandez-Herrero L.A., Laible G., Dull M., Grosschedl R. Extension of chromatin accessibility by nuclear matrix attachment regions. Nature 1997, 385:269-272.
21. Khan W.N. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase. Immunol. Res. 2001, 23:147-156.
22. Kleindienst P., Chretien I., Winkler T., Brocker T. Functional comparison of thymic B cells and dendritic cells in vivo. Blood 2000, 95:2610-2616.
23. Kozmik Z., Wang S., Dorfler P., Adams B., Busslinger M. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell. Biol. 1992, 12:2662-2672.
24. Kumar M., Keller B., Makalou N., Sutton R.E. Systematic determination of the packaging limit of lentiviral vectors. Hum. Gene Ther. 2001, 12:1893-1905.
25. Levine B.L., Humeau L.M., Boyer J., MacGregor R.R., Rebello T., Lu X., Binder G.K., Slepushkin V., Lemiale F., Mascola J.R., Bushman F.D., Dropulic B., June C.H. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17372-17377.
26. Logan A.C., Lutzko C., Kohn D.B. Advances in lentiviral vector design for gene-modification of hematopoietic stem cells. Curr. Opin. Biotechnol. 2002, 13:429-436.
27. Lois C., Hong E.J., Pease S., Brown E.J., Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002, 295:868-872.
28. Lutzko C., Senadheera D., Skelton D., Petersen D., Kohn D.B. Lentivirus vectors incorporating the immunoglobulin heavy chain enhancer and matrix attachment regions provide position-independent expression in B lymphocytes. J. Virol. 2003, 77:7341-7351.
29. Melo M.E., Qian J., El-Amine M., Agarwal R.K., Soukhareva N., Kang Y., Scott D.W. Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases. J. Immunol. 2002, 168:4788-4795.
30. Montini E., Cesana D., Schmidt M., Sanvito F., Ponzoni M., Bartholomae C., Sergi Sergi L., Benedicenti F., Ambrosi A., Di Serio C., Doglioni C., von Kalle C., Naldini L. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat. Biotechnol. 2006, 24:687-696.
31. Moreau T., Bardin F., Imbert J., Chabannon C., Tonnelle C. Restriction of transgene expression to the B-lymphoid progeny of human lentivirally transduced CD34+ cells. Mol. Ther. 2004, 10:45-56.
32. Moreau T., Barlogis V., Bardin F., Nunes J.A., Calmels B., Chabannon C., Tonnelle C. Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA. Gene Ther. 2008, 15:942-952.
33. Naldini L. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. Biotechnol. 1998, 9:457-463.
34. Parekh V.V., Prasad D.V., Banerjee P.P., Joshi B.N., Kumar A., Mishra G.C. B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells: role of TGF-beta 1. J. Immunol. 2003, 170:5897-5911.
35. Redmond W.L., Sherman L.A. Peripheral tolerance of CD8 T lymphocytes. Immunity 2005, 22:275-284.
36. Reis e Sousa C. Dendritic cells in a mature age. Nat. Rev. Immunol. 2006, 6:476-483.
37. Rocha B., Grandien A., Freitas A.A. Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J. Exp. Med. 1995, 181:993-1003.
38. Saoudi A., Simmonds S., Huitinga I., Mason D. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J. Exp. Med. 1995, 182:335-344.
39. Schambach A., Wodrich H., Hildinger M., Bohne J., Krausslich H.G., Baum C. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol. Ther. 2000, 2:435-445.
40. Schwartz R.H. T cell anergy. Annu. Rev. Immunol. 2003, 21:305-334.
41. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003, 21:685-711.
42. Tedder T.F., Inaoki M., Sato S. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 1997, 6:107-118.
43. Uchida N., Sutton R.E., Friera A.M., He D., Reitsma M.J., Chang W.C., Veres G., Scollay R., Weissman I.L. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:11939-11944.
44. Werner M., Kraunus J., Baum C., Brocker T. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element. Gene Ther. 2004, 11:992-1000.
45. Werner-Klein M., Dresch C., Marconi P., Brocker T. Transcriptional targeting of B cells for induction of peripheral CD8 T cell tolerance. J. Immunol. 2007, 178:7738-7746.
46. Woods N.B., Mikkola H., Nilsson E., Olsson K., Trono D., Karlsson S. Lentiviral-mediated gene transfer into haematopoietic stem cells. J. Intern. Med. 2001, 249:339-343.
47. Xu B., Scott D.W. A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP. Clin. Immunol. 2004, 111:47-52.